Showing results (1851-1860 of 1,949) with videos related to

Sort By:
Pageof 195
Journal of Gastroenterology and Hepatology|April 8, 2010
The Asia-Pacific consensus on ulcerative colitisChoon Jin Ooi, Kwong Ming Fock, Govind K Makharia, et al.
BMC Psychiatry|February 23, 2024
Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical featuresShun-Chun Yu, Tzung-Jeng Hwang, Chih-Min Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2024
Inhibition of angiogenesis by the secretome from iPSC-derived retinal ganglion cells with Leber's hereditary optic neuropathy-like phenotypesShih-Yuan Peng, Chih-Ying Chen, Hsin Chen, et al.
ACS Chemical Biology|May 4, 2022
DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug DiscoveryJingyao Li, Daniel J Ho, Martin Henault, et al.
Scientific Reports|March 9, 2022
SSR individual identification system construction and population genetics analysis for Chamaecyparis formosensisChiun-Jr Huang, Fang-Hua Chu, Yi-Shiang Huang, et al.
Cancer Research|November 10, 2021
Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK PathwayAfeez Adekunle Ishola, Chian-Shiu Chien, Yi-Ping Yang, et al.
Frontiers in Cell and Developmental Biology|August 23, 2021
Dual DNA Transfection Using 1,6-Hexanedithiol-Conjugated Maleimide-Functionalized PU-PEI600 For Gene Correction in a Patient iPSC-Derived Fabry Cardiomyopathy ModelChian-Shiu Chien, Yueh Chien, Yi-Ying Lin, et al.
Scientific Reports|March 1, 2022
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapyPo-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, et al.
The Lancet. Respiratory Medicine|June 2, 2020
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trialYi-Long Wu, Ying Cheng, Jianying Zhou, et al.
Nature Cell Biology|March 30, 2018
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasisHsi-Wen Yeh, En-Chi Hsu, Szu-Shuo Lee, et al.
Pageof 195